Prot #CS2514-2017-0004: A Randomized, Active-Controlled Study to Evaluate the Efficacy and Safety of Intravenous Sulbactam-ETX2514 in the Treatment of Patients With Infections Caused by Acinetobacter baumannii calcoaceticus Complex

Project: Research project

Project Details

StatusFinished
Effective start/end date5/14/19 → 5/14/22

Funding

  • Medpace Clinical Research LLC (Prot #CS2514-2017-0004 // Prot #CS2514-2017-0004)
  • Entasis Therapeutics, Inc. (Prot #CS2514-2017-0004 // Prot #CS2514-2017-0004)